AI-powered case prioritization expedites review of malignant cases: a controlled cross-over study

Overview

In this poster, PathAI presented results of a controlled cross-over study evaluating pathologist workflows with and without TumorDetect, PathAI's AI-powered case prioritization algorithm, in the context of the AISight® Dx platform.

Conclusions

• TumorDetect, an AI-powered case prioritization algorithm for digital pathology workflows, expedites pathologist review of ground-truth malignant cases within a larger set of assigned cases.

• Use of TumorDetect increases pathologist agreement with ground-truth diagnoses.

• While additional studies are needed, algorithms likeTumorDetect have the potential to enable faster turnaround time and efficiency gains in anatomic pathology workflows.

USCAP 2026